References
- Rasool M, Farooq S, Malik A, Shaukat A, Manan A, Asif M, et al. Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients. Saudi J Biol Sci. 2015;22(1):106-11.
- Petrola MJ, Castro AJMD, Pitombeira MHDS, Barbosa MC, Quixadá ATDS, Duarte FB et al. Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. RBHH. 2012;34(5):352-5.
- Kaweme NM, Zhou S, Changwe GJ and Zhou F. The significant role of redox system in myeloid leukemia: from pathogenesis to therapeutic applications. Biomark Res. 2020;8(1):63.
- Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science. 1986;233(4760):212-4.
- Gaman AM, Buga AM, Gaman MA, Popa-Wagner A. The role of oxidative stress and the effects of antioxidants on the incidence of infectious complications of chronic lymphocytic leukemia. Oxid Med Cell Longev. 2014;2014:135-58.
- Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S et al. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients. J Buon. 2010;15(2);330-6.
- Rezaieg NS, Musleh MH. Assessment of the role of oxidative stress and circulating biochemical markers in childhood leukemia. JPCS. 2019;1294(6):062089.
- Al-Maliki AAH, Al-Maliki ADM. Estimation of oxidative stress enzymes and vitamins levels in acute lymphocytic leukemia patients in the governorate of Basrah, Iraq. Trop J Nat Prod Res. 2022;6(4):542-5.
- Singh Y, Bali C. Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation. Cas Rep Oncol. 2013;6(3):585-92.
- Rajeshwari U, Shobha I, Raghunatha R, Andallu B. Oxidative stress and antioxidant status in acute and chronic myeloid leukemia patients. OJBD. 2013;3(3):17-22.
- Pujari KN, Jadkar SP, Kulkarni A, Patil V. Qunantitative variation of erythrocytes catalase and glutathione peroxidase levels in leukemia. J Pharm Biomed Sci. 2011;7(07):1-4.
- Matter Al-Maliki AD, Saud KS. Biochemical action of glucose-6-phosphate dehydrogenase deficieny on some enzymes and trace elements of oxidative stress in favism patients in Basrah governorate, Iraq. Biochem Cell Arch. 2020;20(1):1723-8.
- Cortes J. Natural history and staging of chronic myelogenous leukemia. Hematol Oncol Clin North Am. 2004;18(3):569-84.
- Hole PS, Darley RL, Tonks A. Do reactive oxygen species play a role in myeloid leukemias? Blood. 2011;117(22):5816-26.
- Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, et al. Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the gimema CML working party. Haematologica. 2007;92(1):101-5.
- Balducci L, Dolan D. Chronic Myelogenous Leukemia (CML) in the elderly. Mediterr J Hematol Infect Dis. 2014;6(1):1-2.
- Ahmad R, Singh R, Tripathi AK, Singh RK. Leukocyte superoxide dismutase activity in patients with chronic myeloid leukemia. Rev Bras Hematol Hemoter. 2012;34(5):394-5.
- Shvachko L, Zavelevich M, Gluzman D, Telegeev G. Vitamin E in Chronic Myeloid Leukemia (CML) Prevention. In: P. Erkekoglu, J Scherer Santos. Vitamin E in health and disease-interactions, diseases and health aspects. Intech Open;2021:5772-584.
- Proetel U, Pletsch N, Lauseker M, Müller MC, Hanfstein B, Krause SW, et al. Chronic myeloid leukemia study group, and the schweizerische arbeitsgemeinschaft für klinische krebsforschung (SAKK). Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Ann Hematol. 2014;93(7):1167-76.
- Ammar M, Ben Mahmoud L, Medhaffar M, Ghozzi H, Sahnoun Z, Hakim A, et al. Relationship of oxidative stress in the resistance to imatinib in Tunisian patients with chronic myeloid leukemia: A retrospective study. J Clin Lab Anal. 2020;34(2):1-8.
- Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S and Singh RK. Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia. Singapore Med J. 2010;51(2):110-5.
- Rajeshwari U, Shobha I, Raghunatha R, Andallu B. Oxidative stress and antioxidant status in acute and chronic myeloid Leukemia patients. OJBD. 2013;3(3):17-22.
- Faderl S, Talpaz M, Estrov Z, O’Brien S, Kurzrock R, Kantarjian HM. The biology of chronic myeloid leukemia. N Eng J Med. 1999;341(3):164-72.
- Khoshtabiat L, Mahdavi M, Dehghan G, Rashidi MR. Oxidative stress-induced apoptosis in chronic Myelogenous leukemia K562 cells by an active compound from the Dithio-Carbamate family. APJCP. 2016;17(9):4267-73.
- Singh V, Kharb S, Ghalaut PS,Gupta S. Serum vitamin E in chronic myeloid leukaemia. J Assoc Physicians India. 2000;8(2):201-3.
- Vinturis EGP,Gaman AM. Assessment of oxidative stress in patients with chronic myeloid leukemia depending on associated comorbidities. Current Health Sci J. 2020;46(1):23-30.
- Dong Ch, Zhang N, Zhang L. Oxidative stress in leukemia and antioxidant treatment. Chinese Med J. 2021;134(16):1897-907.
- Rajeshwa U, Shobha I, Raghunatha R, Andollu B. Oxidative stress and antioxidant status in acute and chronic myeloid leukemia patients. OJBD. 2013;3(3A):17-22.